Treatments for primary squamous cell carcinoma and squamous cell carcinoma in situ of the skin: A systematic review and network meta-analysis : Summary of an Agency for Healthcare Research and Quality Comparative Effectiveness Review - 09/01/20
Doi : 10.1016/j.jaad.2019.06.030
Aaron M. Drucker, MD, ScM a, b, c, ⁎ 
, Gaelen P. Adam, MLIS d, Valerie Rofeberg, ScM d, Abhilash Gazula, MPH d, Bryant Smith, MPH d, Farah Moustafa, MD c, Martin A. Weinstock, MD, PhD c, Thomas A. Trikalinos, MD d
, Gaelen P. Adam, MLIS d, Valerie Rofeberg, ScM d, Abhilash Gazula, MPH d, Bryant Smith, MPH d, Farah Moustafa, MD c, Martin A. Weinstock, MD, PhD c, Thomas A. Trikalinos, MD d a Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
b Women's College Research Institute and Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada
c Department of Dermatology, Alpert Medical School of Brown University, Providence, Rhode Island
d Center for Evidence Synthesis in Health, Brown University School of Public Health, Providence, Rhode Island
∗Correspondence to: Aaron Drucker, MD, ScM, Women's College Hospital, 76 Grenville St, Rm 6401, Toronto, ON M5S1B2, CanadaWomen's College Hospital76 Grenville St, Rm 6401TorontoONM5S1B2Canada
| Funding sources: This report is based on research conducted by the Brown Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality, Rockville, Maryland (Contract No. 290-2015-00002-I). |
|
| Conflicts of interest: In the last 3 years, Dr Drucker has served as an investigator for and has received research funding from Sanofi and Regeneron and has been a consultant for Sanofi, RTI Health Solutions, Eczema Society of Canada, and Canadian Agency for Drugs and Technology in Health. He has received honoraria from Prime Inc, Spire Learning, CME Outfitters, Eczema Society of Canada, and the Canadian Dermatology Association. His institution has received educational grants from Sanofi and AbbVie. Dr Weinstock has served as consultant for AbbVie and Celgene. Gaelen P. Adam, Valerie Rofeberg, Abhilash Gazula, Bryant Smith, Dr Moustafa, and Dr Trikalinos have no conflicts of interest to declare. |
|
| An abstract related to this work was presented at the 76th Annual Meeting of the Society for Investigative Dermatology, Portland, Oregon, April 26-29 2017. |
|
| Disclaimer: The findings and conclusions in this document are those of the authors, who are responsible for its contents; the findings and conclusions do not necessarily represent the views of Agency for Healthcare Research and Quality. Therefore, no statement in this report should be construed as an official position of Agency for Healthcare Research and Quality or of the United States Department of Health and Human Services. |
|
| Supplemental appendices, including tables and figures, are published on a publically available URL hosted by the Brown University Center for Evidence Synthesis in Health (code-data-repository). |
|
| Reprints not available from the authors. |
© 2019
American Academy of Dermatology, Inc. Tous droits réservés.
Vol 82 - N° 2
P. 479-482 - février 2020 Retour au numéro
Article précédent
- Trichologic response of platelet-rich plasma in androgenetic alopecia is maintained during combination therapy
- Anthony Ho, Kumar Sukhdeo, Kristen Lo Sicco, Jerry Shapiro
- Pain management in photodynamic therapy: A retrospective cohort study
- James W.L. Denny, Alberto Barea, David Wertheim, Natasha Valiallah, Janakan Natkunarajah
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?